TOLEDO COMMUNITY CLINICAL ONCOLOGY PROGRAM

托莱多社区临床肿瘤学计划

• 批准号: 6143919
• 负责人: PAUL L SCHAEFER
• 金额: $ 33.77万
• 依托单位: TOLEDO COMMUNITY HOSPITAL ONCOLOGY PROG
• 依托单位国家: 美国
• 财政年份: 2000
• 资助国家: 美国
• 起止时间: 2000-08-15 至 2005-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6143919
• 关键词: behavioral /social science research tag; breast neoplasms; cancer information system; cancer prevention; cancer registry /resource; cancer rehabilitation /care; chemoprevention; clinical research; clinical trials; community health services; cooperative study; early diagnosis; health services research tag; human subject; human therapy evaluation; medical rehabilitation related tag; neoplasm /cancer diagnosis; neoplasm /cancer education; neoplasm /cancer therapy; oncology

This application of the Toledo Community Clinical Oncology Program (TCCOP) seeks funding for continuation of its ongoing clinical trials program. TCCOP has grown to a twelve institution regional consortium since 1982, when it was first funded. The catchment area encompasses a population of 1.2 million people in over a 6000 square mile area. Over the past four years of CCOP IV, 454 patients have been enrolled in treatments and 245 in cancer control studies. Strengths of the TCCOP remain a history of an impressive accrual track record; stability of experienced data management staff; dedicated physician participation; leadership in scientific activities of cooperative groups (NCCTG, ECOG, NSABP, RTOG, UMCC); increasing minority participation in resear5chl continuous improvement of data quality and efficiency; and a well established infrastructure to conduct clinical trials. Citizens in the community, realizing the importance of research, have increasingly participated in chemoprevention trials, with 99 BCPT subjects and 220 in PCPT. The STAR Trial is anticipated to enroll at least 240 participants. The aims of this application include more strategies to increase accrual being implemented through more intense attention to screening; expansion of resources for recruitment to clinical trials; developing standards of excellence in research programs; and progress in developing more efficient data management systems. Finally, TCCOP foresees a continuous commitment of support and resources in this community for a highly successful clinical treatment and cancer control/chemoprevention research program.

托莱多社区临床肿瘤学计划（TCCOP）的这种应用寻求延续其正在进行的临床试验计划的资金。自1982年首次资助以来，TCCOP已成长为十二个机构区域财团。集水区包括6000平方英里以上的120万人人口。在过去的四年中，CCOP IV，有454例患者参加了治疗，245例癌症控制研究。 TCCOP的优势仍然是令人印象深刻的应计记录的历史；经验丰富的数据管理人员的稳定性；专门的医师参与；合作团体科学活动的领导力（NCCTG，ECOG，NSABP，RTOG，UMCC）；增加少数群体参与Resear5CHL的持续提高数据质量和效率；并建立了良好的基础设施来进行临床试验。社区中的公民意识到研究的重要性，越来越多地参加了化学预防试验，其中99名BCPT受试者和220名PCPT。预计明星审判将至少注册240名参与者。该应用程序的目的包括更多通过对筛查的更大关注来增加应计的策略；扩展招募资源到临床试验；制定研究计划的卓越标准；并在开发更有效的数据管理系统方面进展。最后，TCCOP预计该社区中的支持和资源是非常成功的临床治疗和癌症控制/化学预防研究计划的持续承诺。